Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gilda Weil-Hillman"'
Autor:
R J Robb, Hank Ja, Mitsuru Tsudo, Gilda Weil-Hillman, Stephan D. Voss, Kazuo Sugamura, Paul M. Sondel
Publikováno v:
The Journal of Experimental Medicine
The expression of the 70-kD beta subunit of the interleukin 2 receptor (IL-2R) has been examined on peripheral blood lymphocytes (PBL) obtained from patients receiving systemic infusions of IL-2. Using monoclonal antibodies directed against p70, flow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::971f759613d3433c5dd8a6bdc0b81140
https://doi.org/10.1084/jem.172.4.1101
https://doi.org/10.1084/jem.172.4.1101
Autor:
Kathleen Schell, Gilda Weil-Hillman, Paul M. Sondel, David M. Segal, Jacquelyn A. Hank, Jeffrey A. Sosman
Publikováno v:
Journal of immunotherapy : official journal of the Society for Biological Therapy. 10(4)
The role of activated T cells in the mediation of antitumor responses has been documented in several experimental models. In some of these, interleukin-2 (IL-2) has been used as a means to induce and expand the antitumor effects of the T cells. IL-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::426383d40d9366211dfd8f1dc34661f1
https://pubmed.ncbi.nlm.nih.gov/1834166
https://pubmed.ncbi.nlm.nih.gov/1834166
Publikováno v:
Cancer immunology, immunotherapy : CII. 31(1)
The in vivo administration of repetitive weekly cycles of interleukin-2 (IL-2) to patients with cancer enhances the ability of freshly obtained peripheral blood lymphocytes (PBL) to lyse both the natural-killer(NK)-susceptible K562 and the NK-resista
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27bd2df5543fb8b368cac1a37cbcd898
https://pubmed.ncbi.nlm.nih.gov/2306756
https://pubmed.ncbi.nlm.nih.gov/2306756
Autor:
Jacquelyn A. Hank, Paul Fisch, Alan J. Bridges, Benjamin P. Chen, Gilda Weil-Hillman, Jeffrey A. Sosman, Oscar R. Colamonici, Michael Uppenkamp, Paul M. Sondel
Publikováno v:
Blood. 74:343-353
Culturing of leukemic blood lymphocytes from a patient with acute T- cell lymphoblastic leukemia (T-ALL) with interleukin-2 (IL-2) yielded T- cell line AK-1 with a remarkable cytotoxic specificity. This line mediated strong lysis of tumor target line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55b913472d4943f99a5cea0004988f96
https://doi.org/10.1182/blood.v74.1.343.343
https://doi.org/10.1182/blood.v74.1.343.343
Autor:
Gilda Weil-Hillman, Jeffrey A. Sosman, Fritz H. Bach, Peter C. Kohler, Paul M. Sondel, Paul Fisch, Jacquelyn A. Hank
Publikováno v:
Critical reviews in oncology/hematology. 9(2)
The potential for immune-mediated destruction of neoplasms was suggested nearly one century ago. Despite this, no "magic bullet" has yet been identified. Nevertheless, the physiology of cell-mediated immune reactions has been well characterized in mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3137f02eae5cc3aa5255954908a869ff
https://pubmed.ncbi.nlm.nih.gov/2663205
https://pubmed.ncbi.nlm.nih.gov/2663205
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.